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Mesoderm and mesodermal structures in the sea urchin embryo are entirely generated by two embryologically distinct populations of
mesenchyme cells: the primary (PMC) and the secondary (SMC) mesenchyme cells. We have identified the extracellular signal-regulated
kinase (ERK) as a key component of the regulatory machinery that controls the formation of both these cell types. ERK is activated in a
spatial-temporal manner, which coincides with the epithelial–mesenchyme transition (EMT) of the prospective PMCs and SMCs. Here, we
show that ERK controls EMT of both primary and secondary mesenchyme cells. Loss and gain of function experiments demonstrate that
ERK signaling is not required for the early specification of either PMCs or SMCs, but controls the maintenance and/or the enhancement of
expression levels of regulatory genes which participate in the process of specification of these cell types. In addition, ERK-mediated
signaling is essential for the transcription of terminal differentiation genes encoding proteins that define the final structures generated by
PMCs and SMCs. Our findings suggest that ERK has a central pan-mesodermal role in coupling EMT and terminal differentiation of all
mesenchymal cell types in the sea urchin embryo.
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The epithelial–mesenchyme transition (EMT)—that is,
the formation of mesenchymal cells from a primitive epithe-
lium—is an essential process that occurs during critical
phases of embryonic development in most metazoans. Dur-
ing this transition, polarized epithelial cells actively down-
regulate cell–cell adhesion systems, acquire a morphology
that is appropriate for migration in an extracellular environ-
ment (i.e., they became mesenchyme) and eventually differ-
entiate into distinct cell types. The mechanisms and
transcriptional control that govern EMT are now being
unraveled in several biological systems, including tissue
culture, tumors and embryos (for recent reviews, see Sav-
agner, 2001; Thiery, 2002). While some information is
available concerning the signals that initiate EMT and the
mechanisms of transcriptional repression that control loss of
epithelial phenotype, little is known about the transcriptional
activators that specify acquisition ofmesenchymal properties.0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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development, as the formation of primary and secondary
mesenchyme in the sea urchin embryo represents a relatively
simple model for studying transcriptional regulation during
EMT. The events and mechanisms that underlie mesoderm
specification in the sea urchin have been described in detail
(Angerer and Angerer, 2003; Ettensohn et al., 2003; McClay
et al., 2000; Oliveri et al., 2002, 2003; Sherwood and
McClay, 1999; Sweet et al., 1999, 2002). Moreover, for its
simple biology and easy case of gene transfer technology, the
sea urchin embryo is particularly suitable for gene network
studies (Davidson et al., 2002a, 2003).
Mesoderm in the sea urchin embryo consists entirely of
two types of mesenchyme cells. Primary mesenchyme cells
(PMCs) are the first mesoderm cells to ingress the blastocoel
before any gut invagination has begun, while secondary
mesenchyme cells (SMCs) enter the blastocoel during the
second half of invagination of the archenteron. PMCs are
destined to give rise exclusively to the larval skeleton,
whereas SMCs produce a variety of differentiated mesoder-
mal cell types: pigment, blastocoelar, circumesophageal
muscle and coelomic pouch cells. Primary and secondary
mesenchyme cells have distinct embryonic origins and are
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the sole descendants of the large micromeres that segregate
as founder cells by an unequal division at the 5th cleavage.
These blastomeres are autonomously programmed by ma-
ternal cues to give rise to skeletogenic cells. SMCs derive
almost entirely from veg2 descendants, that is, from the most
vegetal tier of macromeres that lays above the large micro-
meres at the 60-cell stage. Veg2 descendants also give rise to
the endoderm. The segregation of the prospective SMCs
from the future endoderm in this lineage occurs at late
cleavage stage upon a micromere-induced Delta/Notch sig-
nal. Although different for several developmental aspects,
the two populations of cells giving rise to the embryonic
mesoderm share one important feature: at a certain point of
their developmental history, they undergo EMT.
Despite the high degree of knowledge of the mechanisms
of specification of PMCs and SMCs, little is still known
about what triggers EMT in these cells. It is most likely that
the same signal(s) that govern the occurrence of this
transition also control the activation of genes that specify
the acquirement of mesenchymal properties in these cells.
The knowledge of the signaling pathway that triggers EMT
is therefore a necessary requirement for the identification of
the transcriptional regulators that control the expression of
pan-mesenchymal genes.
Receptor tyrosine kinase (RTK) signaling cascades me-
diated by mitogen-activated protein (MAP) kinase pathways
have an important role in developmental processes which
involve EMT in mammals (Savagner, 2001). We decided to
study the role of this signaling pathway in the sea urchin
embryo with the objective of finding gene regulatory net-
works that are controlled by this signal. We found that the
extracellular signal-regulated kinase (ERK) controls the
EMT of both primary and secondary mesenchyme cells in
the sea urchin embryo. Moreover, our experiments demon-
strate that terminal differentiation of these cell types requires
ERK activation.Materials and methods
Animals
Sea urchins (Strongylocentrotus purpuratus) were
obtained from Pat Leahy (Kerchoff Marine Laboratory,
California Institute of Technology, USA). Spawning was
induced by intracoelomic injection of 0.5 M KCl and
embryos were cultured at 15jC in Millipore filtered Med-
iterranean seawater (MFSW) diluted 9:1 in deionized H2O.
Western and ELISA analyses
To prepare protein extracts, samples of 104 cultured or
1500 injected embryos were collected by centrifugation at
3000 rpm, resuspended in 75 Al cell extraction buffer (10 mM
Tris pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1mM NaF, 20 mM Na4P2O7, 2 mM Na3VO4, 1% Triton X-
100, 10% glycerol, 1% SDS, 0.5% deoxycholate, 1 mM
PMSF) and lysed by freezing–thawing in liquid nitrogen and
37jC thermal bath. After addition of 25 Al of NuPageR LDS
Sample Buffer (0.25 of the total volume; Invitrogen),
extracts were incubated at 70jC for 10 min, centrifuged at
14000 for 15 min, and supernatants stored at  80jC until
use. Samples of 2000 cultured or 500 injected embryos were
run using NuPage 10% Bis-tris Gels (Invitrogen), transferred
to nitrocellulose membrane and blots incubated in Blocking
buffer (5% powder milk in PBS, 0.1%Tween20) for 1 h. Pairs
of identical blots, obtained from gels run in parallel, were
incubated overnight at 4jC with a 1:1000 dilution in Block-
ing buffer of either ones of the following primary antibodies:
a-ERK (P42-44/MAPK polyclonal antibody), or a-P-ERK
(Phospho-P44/42 MAPK [Thr202/Tyr204] E10 monoclonal
antibody) (Cell Signaling). Blots were washed three times
with PBS, 0.1% Tween20 and incubated for 1 h at room
temperature with a 1:1000 dilution in Blocking buffer of
horseradish peroxidase-conjugated goat anti-mouse or anti-
rabbit IgG (Santa Cruz). Protein bands were visualized on
Hyperfilm-ECL films using either the ECLWestern blotting
Detection Reagents (Amersham) or the SuperSignal West
Femto Maximum Sensitivity Substrate (Pierce) kits. When
injected embryos were analyzed, protein band normalization
with a-ERK was performed on the same filter after stripping
of the a-P-ERK antibody.
Quantitative measurements of the levels of total ERK and
phosphorylated ERK (P-ERK) were obtained for each sam-
ple using an ERK(1/2) and ERK(1/2 [pTpY185/187])
ELISA system (BioSource International). Samples of 104
embryos were collected at different stages by centrifuga-
tion at 3000 rpm from cultures in MFSW and processed
following manufacturer’s instructions. Protein extracts
corresponding to 1000 embryos per well were analyzed.
Micromere isolation and culture
Micromere isolation and culture were performed as de-
scribed in Lee et al. (1999) with the following exceptions:
embryos at 16 cells stage were washed in Mg/Ca-free
seawater (MCFSW) and then incubated for 5 min in
MCFSW while pipetting with a Pasteur pipette. In addition,
dissociated embryos were filtered through 60, 40 and 20-Am
nylon membrane before separation on a preformed and
prechilled (4jC) sucrose gradient (5–25%) in Ca-free sea-
water (CFSW). Moreover, 24 h after fertilization, micro-
meres cultured in Petri dishes were washed with MFSW to
remove loosely attached cells. Horse serum (4%; Gibco) was
added at 30 h after fertilization.
Immunostaining
Embryos were fixed by incubation for 5 min in ice-cold
methanol on ice, washed three times with ice cold artificial
seawater, and stored in PBS, 5 mM Na-Azide at 4jC until
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treated with 1% H2O2 in PBS containing 5% goat serum
(GS-PBS) for 1 h. For staining with other mAbs, they were
incubated with GS-PBS alone. Primary antibodies and re-
spective dilutions were: for P-ERK staining, phospho-P44/
42 MAPK [Thr202/Tyr204] E10 mAb (Cell Signaling)
(1:100 in GS-PBS); for PMCs, 1g5 mAb (Hardin et al.,
1992) (1:2 in GS-PBS); for PMCs and SMCs, Meso1 mAb
(Wessel and McClay, 1985) (1:10 in GS-PBS); for hind- and
midgut, Endo1 mAB (Wessel and McClay, 1985) (1:2 in GS-
PBS); for oral ectoderm and foregut, EctoV mAb (Hardin et
al., 1992) (1:5 in GS-PBS). All tissue-specific mAbs were a
generous gift of D. R. McClay. After incubation with the
appropriated primary antibody overnight at 4jC, embryos
were washed three times for 15 min with GS-PBS and
incubated for 2 h with secondary antibody at room temper-
ature. Secondary antibodies and detections were: for anti-P-
ERK, biotinylated goat anti-mouse IgG (Vector Laborato-
ries) (1:200 in GS-PBS) and signals were detected by
immunohistochemistry using the Peroxidase Vectastain Elite
ABC and DAB substrate system (Vector Laboratories)
according to manufacturer’s instruction; for all other mAbs,
fluorescein-conjugated, goat anti-mouse IgG (Jackson
Immunoresearch) (1:200 in GS-PBS) and embryos were
washed three times for 15 min with GS-PBS and directly
mounted on glass slide for fluorescence observation. A Zeiss
microscope equipped with an Axiocam digital camera and a
Zeiss confocal laser scanning microscope were employed to
acquire all DIC and immunofluorescent images shown.
Overlaying of DIC and fluorescent images were obtained
using Photoshop.
Phalloidin staining
Staining of filamentous actin with phalloidin was per-
formed as follows (Burke and Alvarez, 1988 and J. Venuti,
personal communication). Larvae at 96 h of development
were collected by gentle centrifugation (3 min at 1000 rpm),
fixed at room temperature for 10–15 min in 4% Para-
formaldehyde in PBS containing 0.1% Tween20 (PBST),
washed three times in PBST and stored in PBST, 5 mM Na-
Azide at 4jC until use. Phalloidin-FITC (Sigma) was dis-
solved in ethanol (40 AM f.c.) and 10 Al of this solution were
dried out in an Eppendorf tube by speed-vacuuming. Fixed
larvae (150–200 Al in PBST) were added to this tube, gently
mixed and incubated for few minutes on ice. Larvae were
then directly mounted on a glass slide for observation on the
confocal microscope.
Quantitative PCR (QPCR)
Total RNAwas isolated from control (DMSO-treated) and
UO126-treated embryos or micromere cultures. RNA was
extracted using either the Mini or the Micro RNeasy kits
(Qiagen), as described by the manufacturers. First-strand
cDNAwas synthesized using random hexamers and the TaqMan kit (PEByosystems). QPCRwas conducted as described
by Rast et al. (2000) using an ABI Prism 7000 sequence
detection system and SYBR Green chemistry (PE Byosys-
tems). Reactions were carried out in duplicates or triplicates,
which were executed in identical well positions in different
runs, using cDNA from 2 to 3 embryos per reaction as
template. Specific primer sets for each gene were obtained
from Davidson et al. (2002b) and Ettensohn et al. (2003),
except those for erg, actM and sum-1, which were designed
using their known cDNA sequences and the program Primer3
(Rozen and Skaletsky, 2000). For all experiments, raw data
outputs were internally normalized against the ubiquitin
RNA, which is known to be expressed at constant levels
during development (Ransick et al., 2002). Throughout tables
and figures, QPCR results are presented either as fold differ-
ences or as percent of the maximum value. Fold differences
represent the number of times higher or lower the level of
expression was found to be in experimental samples relative
to controls. Percent of maximum indicates the percentage of
expression of each sample as compared to the maximum level
of expression found, among the analyzed samples, for each
primer set specific for a given gene. Both calculations used
the formula 1.9DCt, where 1.9 is the multiplier for amplifica-
tion per PCR cycle, and DCt is the cycle threshold difference
with ubiquitin found for that sample.
MEK constructs, mRNA preparation and microinjection
Mekact and Mekneg expression plasmids were constructed
by subcloning into the pBlueScript NR3 plasmid (Lemaire et
al., 1995) a 1.5-kb BamHI toHindIII fragment containing the
entire coding sequence of the DN3-S218E-S222D and the
K97M MEK mutant (Mansour et al., 1994), respectively.
After linearization at the SfiI site, 1 Ag of the plasmid was
used as template to generate in vitro transcribed 5V-capped
mRNAs using the T3 mMessage mMachine kit (Ambion) as
described in the manufacturer’s manual. The mRNA was
purified on a Sephadex G-50 column (Pharmacia) to remove
free nucleotides, quantified by spectrophotometry and
checked by gel electrophoresis. Injection solutions were
prepared in RNase-free H2O (Ambion) at mRNA concen-
trations ranging from 50 to 200 ng/Al in the presence of 0.12
MKCl. Eggs were prepared and injected as described byMao
et al. (1996), using 0.12 M KCl injection solution as control.Results
ERK in situ activation atlas during sea urchin
embryogenesis
Mitogen-activated protein (MAP) kinase kinase (MEK)
and extracellular signal-regulated kinase (ERK) are essential
downstream components of the receptor tyrosine kinase
(RTK) signaling pathway (Marshall, 1995; Schlessinger,
2000). RTK signaling pathways may be tackled by follow-
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active kinase intermediates are covalently modified by
phosphorylation and can thus be distinguished from the
non-active forms. To establish the role of this pathway in
the sea urchin embryo, we decided to follow the spatial
and temporal dynamic of ERK activation, since ERK
represents one of the terminal steps in the signaling
cascade. Moreover, ERK proteins and their activation
loops are highly conserved in evolution (Boulton et al.,
1990; Widmann et al., 1999) and antibodies are available
which specifically recognize either the phosphorylated
(active) form or the whole protein in different species.
We used these tools to determine the time course of
activation of ERK during sea urchin development. Western
blot analysis of sea urchin protein extracts using an
antibody against P42/P44 ERK mammalian forms reveals
a single immunoreactive band at 43  103 Mr (Fig. 1A),Fig. 1. Time course activation analysis of ERK during sea urchin
development. (A) Western analysis of protein extracts (2000 embryos per
lane) with either anti-ERK or anti-P-ERK antibodies reveals a single band
of about 43,000 Mr for each developmental stage analyzed: 5th cleavage,
hatching blastula (HB), blastula (B), mesenchyme blastula (MB), early
(EG) and late (LG) gastrula. In the two lanes on the extreme right, protein
extracts prepared from approximately 500 embryos injected with either
Mekact mRNA or KCl alone are analyzed to show the relative increase of P-
ERK labeling in response to ERK overactivation (Fig. 5). Protein band
normalization with anti-ERK was performed on the same filter after
stripping of the anti-P-ERK antibody. (B) ELISA analysis of P-ERK/ERK
ratios at various developmental stages. Arbitrary units of P-ERK (U P-
ERK) and pg of total ERK (pg ERK) were calculated using known
standards of P-ERK protein. Ratios of U P-ERK/pg ERK were normalized
at each stage for the number of cells positive to anti-P-ERK (counted from
embryos stained with anti-P-ERK as reported in Fig. 2), assuming that total
ERK is equally expressed in all of the embryo cells (not shown).as calculated from its intermediate migration between the
P42 and P44 human forms (not shown). The profile of
activation of ERK during embryo development was deter-
mined by measuring the ratio between phosphorylated and
whole enzyme in protein extracts at different developmen-
tal times, using both Western blot and ELISA analyses.
Fig. 1B shows that a first peak of activation occurs at
early blastula stage, few hours before first ingression of
primary mesenchyme cells. The level of ERK activation
per cell slightly decreases after this peak and reaches a
minimum around 23 h, when all mesenchyme cells are
ingressed, and increases again when archenteron invagi-
nation initiates (32 h). Considerably high levels of active
ERK are retained throughout archenteron elongation and
secondary mesenchyme cell delamination, until 48 h of
development.
The spatial pattern of ERK activation was determined
by whole-mount immunohistochemistry, using an antibody
against the double phosphorylated/active form of ERK.
Fig. 2 shows the result of this analysis. Double phosphor-
ylated/active ERK was found during cleavage (up to 10–
12 h of development) uniformly distributed in the cyto-
plasm of all the cells of the embryo (not shown). At early
blastula stage (13–15 h), active ERK is exclusively
detected at the center of the vegetal plate in an irregular
ring of cells that by number and position are likely to
include most of the large micromeres progeny (i.e., the
primary mesenchyme cells) and excludes the small micro-
meres (Fig. 2A). The apical staining observed in lateral
views of these blastulae (Figs. 2B and 2C) is probably
due to the nuclear localization of active ERK in these
cells. Later on, just before primary ingression initiates (19
h), the ring of stained cells expands into a crescent which
includes presumptive secondary mesenchyme cells, but
possibly excludes PMCs, as deduced by counting the
number of unstained cells at the center of the ring visible
in Fig. 2D. During PMC ingression, the staining is
progressively lost by PMCs and acquired by presumptive
SMCs. The analysis of the spatial distribution of active
ERK in a large number of embryos aged between 19 and
24 h led to the conclusion that ERK is transiently
activated in PMCs, prior and during their ingression (data
not shown). The temporal pattern of activation is such that
not all PMCs show high levels of activated ERK at the
same time. When the process of primary ingression is
completed, at the mesenchyme blastula stage, staining is
no longer observed in PMCs and it is now confined to an
asymmetric but filled circle of cells at the vegetal plate,
most probably including the entire non-skeletogenic mes-
odermal lineage (Figs. 2E and 2F). A few hours later,
active ERK is localized in a group of cells at the tip of
the invaginating archenteron (Fig. 2G). The staining at the
tip of the archenteron has an oral bias that is retained until
the end of gastrulation (Fig. 2I), when the gut reaches the
roof of the blastocoel and active ERK is also observable
in some cells of the oral ectodermal wall near the tip of
Fig. 2. Immunohistochemical analysis of ERK activation during sea urchin embryogenesis using anti-P-ERK antibodies. Vegetal (A) and lateral (B) view of
early blastula stage embryos showing ERK activation in prospective PMCs. (C, D) A late blastula displayed in both lateral (C) and vegetal (D) views shows an
asymmetric ring of activation of ERK in the vegetal domain of the embryo. (E, F) A mesenchyme blastula viewed in lateral (E) and vegetal (F) orientation
shows ERK activation in prospective SMCs, but not in ingressed PMCs (F, arrow). (G) Early gastrula showing ERK activation in the cells at the tip of the
invaginating archenteron. Note that staining is absent in the PMCs at the vegetal pole (arrow) and in the secondary mesenchymal cells that are migrating
towards the roof of the blastocoel (arrowheads). (H, I) A late gastrula in two different orientations: the oral view (H) shows strong P-ERK staining at the tip of
archenteron and in the ectoderm above it (arrowhead); the vegetal view shows the oral bias of the staining at the tip of the archenteron. (J) An early prism stage
viewed from the animal pole shows distinct nuclear expression in a pouch of about eight ectodermal cells. (K, L) The same pluteus viewed in different
orientations: from the side (K), to show staining in the mouth (m), at the tip of the elongating anal arm (arrow) and at the level of the foregut (fg)–midgut (mg)
junction (arrowhead); from the oral surface (L), which shows ERK activation on the ventral side of the foregut and in the proximal aspects of coelomic pouches
(cp), stronger on one side (arrow).
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active ERK was also observed in the oral ectoderm at all
gastrula stages analyzed (not shown). The strongest ecto-
dermal staining is observed at 50 h in a patch of 8–10
cells located just above the tip of the archenteron, where
the mouth will open (Fig. 2J). ERK activation at the
stomadeum is clearly visible in larvae at 72 h of devel-
opment, along with a strong activation in the nascent
coelomic pouches and in the foregut, specially on the oral
aspects of the fore–mid gut junction (Figs. 2K and 2L).
Considerable levels of active ERK are also visible in the
elongating anal arms of these larvae. In conclusion, the
atlas of ERK in situ phosphorylation during sea urchin
development highlights a dynamic pattern of activity of
this kinase in a variety of cell types. These cells have
different lineages and fates, but all share a common
behavior: they are in the process of moving and/or changing
shape.Role of ERK activation in sea urchin development
To confirm that in the sea urchin ERK is activated by
the kinase MEK, as it occurs in all the systems so far
studied (for a recent review, see Chang and Karin, 2001),
and to assess the role of this signaling pathway in embryo
development, we used a specific inhibitor of MEK activity,
UO126 (Favata et al., 1998). When UO126 was added at 9
h of development, further phosphorylation of ERK was
blocked, as demonstrated by the Western blot analysis
shown in Fig. 3A. The first observable phenotypic effect
of inhibition of ERK activation is the absence of PMC
ingression at blastula stage (Table 1, type 2; compare Figs.
3B and 3F). At the time when, in control embryos, all
PMCs have ingressed into the blastocoel and arranged as a
ring (32 h) to eventually form the two ventrolateral clusters
where spiculogenesis will begin (48 h), and when SMCs
emerged from the tip of the invaginating archenteron (32–
Fig. 3. Morphological and cell fate alteration following inhibition of ERK activation in S. purpuratus embryos. (A) Western blot analysis shows that UO126-
treated embryos lack phosphorylated ERK (P-ERK), but keep normal levels of total ERK. (B–M) DIC images of control (DMSO-treated; B–E) and UO126-
treated (10 AM in F, H–M; 2 AM in G) embryos at various stages of development. The drug was added at 9 h post-fertilization in all cases. Control blastulae
show normal PMC ingression (B, arrow), while treated blastulae lack PMCs (F). Control gastrulae present normal gastrulation, spiculogenesis (C, D, arrows)
and pigment cell formation (red cells in C), while treated gastrulae lack most mesenchyme cells (G, H) and in most the cases gut evaginates (H). Control larvae
are pigmented and present normally triradiated spicules (E, arrow), while treated larvae (I) are spicule-less and almost pigment-less, but with a normal ciliary
band (I, arrowhead) and tripartite gut (I, arrow). Removal of the drug after 24 h of development, completely rescues pigmentation (red cells in J and K), but
only partially rescues spiculogenesis (K–M). In some cases, mesenchyme cells are arranged as a ring, but do not form spicules (K, arrow). In other larvae,
spicules form but lack the typical triradiate structure (L and M, arrows).
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coel, void of primary and secondary mesenchyme cells
(compare Figs. 4A and C with B and D). Depending on
the concentration of drug used, two different gut pheno-
types were observed. At low doses of UO126 (2 AM), the
gut invaginated and elongated into the blastocoel in most
of the embryos, even if on a delayed schedule (Fig. 3G).
At higher drug doses (10 AM UO126), embryos showed
exogastrulation (Table 1, type 2 and Fig. 3H). In both
cases, mesenchyme cells were absent or strongly reduced
in number, whereas the gut differentiated into a tripartite
structure (Figs. 3H and 3I). This was confirmed by the
correct expression of the Endo1 antigen in the evaginatinghindgut (Fig. 4F). At the end of embryo development,
when control larvae displayed elongated spicules and
pigmented ectoderm, UO126-treated larvae were spicule
and almost pigment-less (Table 1, type 2; compare Figs.
3E and 3I). Nonetheless, treated larvae formed a correct
stomadeum with a fully developed ciliary band (Figs. 3I
and 4H).
Because inhibition of ERK activation caused phenotypic
alterations of morphological events occurring at different
times of development (e.g., formation of mesenchyme cells
and their derived structures), we examined when and for how
long ERK activation is required in normal embryo develop-
ment by phenotyping embryos that were exposed for differ-
Table 1
Effects on sea urchin embryo development following inhibition of ERK activation by UO126
n.c., not counted, but present, pigment cells.
n, number of embryos examined. For each treatment, two or more independent experiments were performed on approximately equal numbers of embryos and
the data pooled.
aEmbryos were allowed to grow in seawater containing 10 AM UO126 dissolved in DMSO. Control embryos were grown in the presence of the same amount
of DMSO used to dissolve the drug.
bDrawings depict the most represented phenotype (more than 50% of the embryos analyzed) at 48 h. Four different phenotypes were observed. Type 1, normal
embryo. Type 2, exogastrula with very few scattered mesenchyme cells and no pigment cells. Type 3, endogastrula with several mesenchyme cells scattered in
the blastocoel and reduced pigment cells dispersed in the ectoderm. Type 4, endogastrula with short and narrow archenteron and few scattered mesenchyme
cells.
cEmbryos were scored for the presence of ingressed PMCs at 24 h and for the formation of a ring of PMCs at 48 h.
dEmbryos were scored for the presence of a triradiate spicule primordium at 48 h and for the presence of skeletal rods at 72 h.
eRed pigment cells (PC) were counted using DIC optics (see Figs. 4E and 3I as examples). Minimum and maximum numbers of PC per embryo are reported.
f Pigment cells in these embryos have a spherical shape and are smaller than control (see Fig. 3H for an example). The number reported could be over-
estimated, due to the low stability of the diluted drug during extended periods of time.
gSpicules in these embryos never present the characteristic 3D pattern typical of controls at the same stage (compare Figs. 3E and 3M). Often only one skeletal
rod is present (an example is reported in Fig. 3L).
hPMCs in these embryos arrange as a ring but no cluster or spicule primordium is visible.
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analyzed for the occurrence and timing of four distinct
morphological events: PMC ingression, exogastrulation,
spicule and pigment cell formation. The latest time when
the drug could be added and PMC ingression still blocked
occurred between 12 and 15 h of development (Table 2,
treatments 2–4). A correct number of PMCs ingressed at the
right time compared to control in 100% of the embryos
treated from 15 h and in 25% of the cases analyzed, they
were eventually arranged as a ring (Table 1, type 4). This
indicates that ERK activation before 15 h of development is
required for proper primary ingression of mesenchyme. A
similar temporal window was determined for correct gastru-
lation: exogastrulation occurred in a significant percent of
cases only if the drug was added before 15 h (Table 1, type 2
and 4; Table 2, treatments 2–6). ERK activation is requiredthroughout the process of spiculogenesis. Spicule formation
was in fact blocked even when the drug was added after 32
h of development, when all skeletogenic mesenchyme had
already ingressed and arranged as a ring (Table 2, treatments
5–7). Moreover, exposure to the drug from 12 to 24 h was
sufficient to irreversibly impair spiculogenesis (Table 1, type
3; Table 2, treatments 8 and 9). Spicules were formed in these
conditions only in a limited number of embryos ( < 15%), on
a delayed schedule (after 60 h of development), and never
showed a correct 3D structure (see Figs. 3L, M). On the other
hand, development of pigment cells, for which ERK activa-
tion is necessary throughout the process of delamination
from the tip of the archenteron, migration to the ectodermal
wall and formation of pigmented granules (from 32 to 60 h;
Table 2, treatments 6 and 7), is partially rescued when the
drug is removed at 24 or 32 h (Table 1, type 3; Table 2,
Fig. 4. Staining of tissue-specific antigens in DMSO (control) and UO126-
treated embryos. (A–D) are two-dimensional projection of confocal images;
(E–H) are composed of false color fluorescent images overlaid on DIC
exposures. (A, B) Early gastrula stage embryos stainedwith the PMC-specific
mAb 1d5 showing a normal ring of PMC in control (A, arrowhead) and only a
single cell (B, arrow) in the UO126-treated specimen. (C, D) Staining of the
PMC- and SMC-specific mAb Meso1 showing two clusters of PMCs near
the vegetal pole (arrowheads) and SMCs at the tip of the archenteron (arrow)
in control gastrulae, compared to an empty blastocoel in a treated embryo of
the same age. (E, F) Endo1 antigen expression (red) in the hind–midgut
region of a control early pluteus and in the most proximal region of the
evaginated archenteron in a UO126-treated embryo of the same age. (G, H)
EctoVantigen expression (green) showing correct oral/aboral differentiation
in the ectoderm of UO126-treated larvae as compared to control plutei.
Abbreviations are CB, ciliary band; FG, foregut; HG, hindgut; MG, midgut.
M. Fernandez-Serra et al. / Developmetreatments 8 and 9; Figs. 3J–M). Short exposures of embry-
os even to high doses of UO126 between the 12- and 19-
h interval delayed normal development (Table 2, treatments
10 and 11).Position of the ERK-mediated signaling pathway in the
endomesoderm specification network
The most striking phenotype observed in embryos
where ERK activation had been blocked was the pertur-
bation in the formation (block of EMT) of both primary
and secondary mesenchyme cells and their derived struc-
tures. As a regulatory gene network that controls the
process of specification of these cell types has been
recently proposed (Davidson et al., 2002a,b), we under-
took a detailed analysis of the role of ERK-mediated
signaling in this network. We used QPCR to measure
the levels of expression of 17 genes expressed in different
domains of the embryo after UO126-mediated inhibition
of ERK activation. Genes belongings to three groups
based on their domain of expression were considered:
genes expressed exclusively or selectively in cells of the
prospective skeletogenic lineage prior and/or after primary
mesenchyme ingression; genes restricted to the veg2
prospective mesodermal domain prior gastrulation and
eventually expressed in secondary mesenchyme cells;
genes belonging to the endomesodermal pregastrular do-
main and/or expressed in the definitive endoderm. The
results of this analysis are reported in Table 3. Blockage
of ERK activation had no detectable effect on levels of
five of the mRNAs at the developmental times tested
(ranging from 15 to 48 h): bra, gataE, lim and foxA, all
belonging to the endomesoderm/endoderm domain (David-
son et al., 2002b), and delta, which is expressed in
prospective skeletogenic and veg2 mesenchymes (Oliveri
et al., 2002; Sweet et al., 2002). The levels of eve (Ransick
et al., 2002) and elk (Livigni and Arnone, unpublished)
mRNAs were slightly diminished in ERK blocked embryos,
when assayed during gastrulation (32 and 48 h), but were
not affected at blastula stage. The mRNA levels of six
transcription factors specific of the prospective or definitive
mesenchyme lineages were considerably diminished after
perturbation of ERK activation: alx1 (Ettensohn et al.,
2003), ets1 (Kurokawa et al., 1999), tbr (Croce et al.,
2001; Fuchikami et al., 2002), dri (Amore et al., 2003),
gcm (Ransick et al., 2002) and erg (Fernandez-Serra and
Arnone, unpublished; Zhu et al., 2001). The mRNA levels
of four terminal differentiation genes, exclusively expressed
in PMCs, msp130 (Parr et al., 1990) and sm50 (Katoh-Fukui
et al., 1991), or SMCs, dpt (Rast et al., 2002) and pks
(Calestani et al., 2003) were strongly down-regulated fol-
lowing inhibition of ERK activation.
MEK/ERK signaling pathway controls spicule and pigment
cell formation
In mammals, MEK has been characterized as the kinase
that specifically activates ERK. A constitutively active
MEK mutant has been described that has basal activity
over 400 times greater than that of the unphosphorylated
wild-type kinase and does not require extracellular signal-
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Table 2
Temporal window of sensitivity to UO126
a
Embryos were allowed to grow in seawater (dotted line) or seawater containing 10 AM UO126 (thick black line) for the interval of time indicated. Arrows
indicate the time of onset, observable in normal condition, of ingression (I), gastrulation (G), spicule (S) and pigment granules (P) formation.
b
Embryos were scored for the presence (+) or absence ( ) of the indicated morphological feature in at least 95% of the observed cases. PMC ingression was
monitored between 19 and 28 h. Other morphologies were observed between 48 and 60 h. Average 100 embryos were analyzed for each experimental
condition.
c
In these conditions 5–20% of the embryos showed exogastrula.
d
Spicules in these conditions are abnormal and present in less than 15% of the cases observed.
e
Average 5–20 pigment cells per embryo were observed in these embryos.
f
Normal, but delayed, morphogenesys.
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of the MEK-specific noncompetitive inhibitor UO126 in
blocking sea urchin ERK phosphorylation demonstrated by
our experiments suggested that this mammalian MEK
mutant (Mekact) could be used to constitutively activate
the kinase ERK in sea urchin embryos. We first examined
the pattern of ERK activation in Mekact mRNA-injected
embryos. Injection of Mekact mRNA ectopically activates
ERK in all domains of the embryo as assessed at the
blastula stage (compare Fig. 5F with Fig. 2E; for a
quantitative measurement, see Fig. 1A). Mekact overexpres-
sion in sea urchin embryos showed a typical dose-depen-
dent response. Embryos injected with high levels (2.0–4.0
pg) of Mekact mRNA, underwent normal development up to
mesenchyme blastula stage; ingression of PMCs occurred at
the right time in an apparent regular fashion. At the time,
when in control embryos, the vegetal plate begun to
invaginate and form the archenteron, most of Mekact-
injected embryos (60–70%) formed an indistinct and thick
mass at the vegetal plate and the blastocoel filled with
mesenchyme cells. By 48 h of development, end of
gastrulation in control embryos, most of these cells showed
pigmentation (Fig. 5B). A minority (10–15%) of theinjected embryos extruded a large number of mesenchymal
cells most of which became pigmented at around 48 h of
development (Fig. 5C). In 10–15% of the cases, gastrula-
tion progressed even if on a strongly delayed schedule: the
archenteron elongated, short spicules formed and several
mesenchymal cells, mostly pigmented, migrated within the
blastocoel (Fig. 5E). Injection of low levels (0.2–0.5 pg) of
Mekact increased (up to 80%) the number of embryos that
showed the latter phenotype. Remarkably, at both low and
high doses of injected mRNA, several embryos eventually
formed a larva, although development was strongly
delayed. A typical 5 days old larva obtained in these
experiments is shown in Fig. 5H in comparison with a 4-
day pluteus control from the same batch (Fig. 5G). Injected
larvae were highly pigmented and showed abnormal but
elongated spicules with a peculiar multibranched structure
(Fig. 5H, detail).
Mansour et al. (1994) also described a catalytically
inactive form of MEK (K97M) that acts as a dominant
negative protein. The high degree of identity in the
primary structure between human and sea urchin MEK
(average 90% in the catalytic domain; Rizzo and Arnone,
unpublished) suggested that this mutant (Mekneg) could be
Table 3
Effects on expression levels of various genes following inhibition of ERK activation
Gene Typea Domain b Fold-differencec
of expression
15 h 21 h 24 h 32 h 48 h
delta L PMC/SMC  1.9,  2.7  1.6,  3.6  2.8,  3.7 1.0  1.5
ets1d TXF PMC/PMC + SMC 1.0,  1.7  3.0,  1.5  4.6  5.4  4.2
tbrd TXF PMC + 1.2  3.6,  3.7,  2.6  3.6  14.0  15.6
alx1 TXF PMC  5.3,  2.3  3.6  6.9  
dri TXF PMC/OE  12.4,  10.1  5.0 – – –
sm50 TDG PMC –  10.8  25.1  29.3  85.2,  131.4
msp130 TDG PMC –  57.7  15.0  7.8 –
gcm TXF M/SMC  1.7  4.6,  2.7  4.6,  6.8  4.0  3.8
erg TXF M/SMC + PMC  8.2  4.6,  3.6,  4.2  21.4  3.7  4.2
dpt TDG M/SMC –  5.0  4.4  5.6  13.7
pks TDG M/SMC  8.4  10.2,  10.6  15.0  9.2  30.4
bra TXF EM/E + OE + 1.2,  2.3  1.4,  1.7  1.1 + 1.4  1.5
gataE TXF EM/E –  1.4 + 1.2  2.6  2.9
lim TXF E/OE –  1.9  1.6 + 1.4  2.8
foxA TXF EM/E –  1.4  1.1  1.1  2.2
eve TXF E/AE – + 1.1  2.2  4.4  4.8
elk TXF EM/E + OE –  2.0  1.6  1.3  5.0
a Genes were classified as transcription factors (TXF), ligand (L) and terminal differentiation genes (TDG).
b Domain of expression in untreated embryos at the times indicated on the Table: E, prospective and definitive endoderm; EM, veg2 endomesoderm; M, veg2
mesoderm; OE, oral ectoderm; PMC, prospective skeletogenic or primary mesenchyme cells; SMC, secondary mesenchyme cells of veg2 origin. Where
different embryonic territories separated by slashes are reported, the left one(s) refer to pregastrular expression pattern (15, 21 and 24 h) and the second one(s)
to the postgastrular domain (32 and 48 h).
c The levels of expression of each gene were measured at different time of development by QPCR, using template cDNA prepared from UO126-treated (from 9
h) embryos compared to control embryos at the same developmental time. The results are presented as the number of times the transcript level per embryo is
lower (negative) or higher (positive) than control levels. The fold-differences are calculated from cycle threshold (CT) data normalized to CT values for
ubiquitin in each sample (DCT), by using the formula described in Materials and methods. Figures in bold indicate significant effects, where significant means
more than 3.6-fold increase or decrease from control transcript levels (normalized CT difference from control is < 2 or >2). A value of 1.0 indicates no
difference between control and experimental samples. Commas separate measurements in different batches of cDNA from independent experiments. Primer
sets specific for the genes analysed, except for erg (this study) and alx1 (Ettensohn et al., 2003), were obtained from Davidson et al. (2002b).
d These genes are expressed since egg stage. The primers used in this study do not distinguish between maternal and zygotic mRNA.
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of Mekneg mRNA (2.0–4.0 pg) resulted in embryos negative
to anti-P-ERK staining (not shown). In these embryos, PMCs
never ingressed (Fig. 5J), gastrulation was delayed and the
number of SMCs strongly reduced (Fig. 5L). These embryos
are phenotypically similar to UO126-treated embryos (com-
pare Figs. 5J and L with 3F and G), thereby confirming drug
specificity. To further validate our drug studies, we tested the
possibility of rescuing the effects of UO126 by overexpres-
sion of activated MEK. Since UO126 is a competitive
inhibitor of both wild type and constitutively active MEK
(Favata et al., 1998), we performed an experiment in which
Mekact-injected embryos were exposed to different concen-
trations of the drug. The results of this analysis are reported
in Table 4. As expected, injection of high doses of Mekact
mRNAwas able to rescue UO126 effects in a concentration-
dependent manner.
ERK-mediated signaling is necessary for micromere
autonomous specification
Because inhibition of ERK activation in the whole
embryo blocked the process of formation and differentia-
tion of PMCs at the level of primary ingression, we asked
the question whether the observed subsequent effects onspiculogenesis (absence of spicules; down-regulation of
PMC-specific genes) were a consequence of the death of
these cells. To rule out this possibility, we tested if and
how ERK-mediated signaling could interfere with the
process of spicule formation in vitro. Micromeres were
isolated from 16-cells embryos and cultured in vitro for 2–
3 days in seawater in the presence or absence of 4%
serum. UO126 was added to block further activation of
ERK together with horse serum at 30 h post-fertilization.
Spicule growth was observed by 72 h and elongated,
branched spicules were formed by 96 h in control cultures
(seawater containing 4% serum; Figs. 6A, B) but not in
UO126-treated cultures (seawater containing 4% serum
and 10 AM UO126; Fig. 6C). By close microscopic
inspection, drug-treated micromere cultures closely resem-
bled those cultured in the absence of serum (McCarthy and
Spiegel, 1983). Micromeres remained round throughout the
culturing period and aggregated only as rosette-like cluster
of cells without any evident pseudopodial network forma-
tion (not shown). This result suggested that intracellular
ERK activation is required for transduction of the still
unknown signaling pathway triggered by serum. To
strengthen this observation, we measured and compared
the levels of expression of six PMC-specific genes in four
experimental conditions: whole embryos, micromeres cul-
Fig. 5. Injection ofMekact andMekneg affects mesenchyme, pigment cell and spicule formation. (A, D, G) Control (KCl-injected) embryos at late gastrula (48 h,
A), early (70 h, D) and late (90 h, G) pluteus stages showing normal pigment, gut and spicule formation. (B, C) Late gastrulae (same age as control in A)
injected with Mekact (2.0–4.0 pg) have an increased number of pigment cells that extrude in some cases (C). (E) Mekact-injected (2.0–4.0 pg) embryo at the
same age as the pluteus showed in (D) shows increased number of pigment cells in the whole ectoderm and abnormal, retarded gut and spicule formation. (F) A
blastula stage embryo injected with Mekact (0.2–0.5 pg) stained with anti-P-ERK antibody shows ERK activation in the whole embryo. (H) Five-day-old larva
injected with Mekact (0.2–0.5 pg) presents partial rescue of development. Abnormalities in number of pigment cells and spicule structure are displayed in the
insert, which shows an enlarged surface focal plane of the anal arm region (compare with a similarly focused insert in the control, G). (I –L) Injection ofMekneg
mRNA (2.0–4.0 pg) blocks PMC ingression and reduces SMC formation. (I, K) Control (KCl-injected) mesenchyme blastula (24 h) and late gastrula (48 h)
display several PMCs and SMCs. (J, L) Mekneg-injected embryos present an empty blastocoel at 24 h and only few mesenchyme cells appearing by 48 h.
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 – 100% (70) 0 0 0
 0.01 100% (60) 0 0 0
 0.1 100%c (72) 0 0 0
 1 0 100% (42) 0 0
+ 0.01 25%d (18) 0 25% (18) 50% (36)
+ 0.1 47% (28) 0 53% (32) 0
+ 1 36% (28) 64% (50) 0 0
a Zygotes were injected with 2.0–4.0 pg of Mekact mRNA in 0.12 M KCl (+) or with KCl alone ( ) and 9 h after fertilization UO126 was added at the
indicated concentration.
b When controls reached pluteus stage (72 h), embryos were scored for gut, spicule and pigment cell (PC) formation. The number of embryos showing the
described phenotype is indicated in parentheses next to the percent over the total number of embryos analyzed.
c These plutei showed a slightly reduced number of pigment cells (20–25 PCs/embryo) compared to controls (30–35 PCs/embryo).
d These plutei showed a slightly increased number of pigment cells (40–45 PCs/embryo) compared to controls.
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taining serum, micromeres cultured in seawater containing
serum and UO126. Fig. 6D shows the results of thisFig. 6. Inhibition of ERK activation blocks spiculogenesis and reduces skeletogeni
h micromeres cultures obtained in the presence of 4% horse serum (HS) showing
spicules consequent to the addition of UO126 at 30 h post-fertilization (C). Scale ba
UO126 treatment in serum-activated cultured micromeres. mRNA levels were mea
indicated developmental times and 72 h micromere cultures deriving from the same
seawater containing 4% horse serum (HS) and seawater containing 4% horse seru
ubiquitin CTs and results were expressed as percent of the maximum (% of MAXanalysis. The mRNAs of two of these genes, ets1 and
tbr, are of maternal origin and therefore high levels of
these transcripts were detected in the whole embryo at 4 h ofc-specific gene expression in isolated micromeres. (A–C) DIC images of 95
the formation of several elongated spicules in control (A, B) and absence of
rs are 20 Am. (D) Effect on expression levels of skeletogenic genes following
sured by QPCR from cDNA templates prepared from whole embryos at the
batch of fertilized eggs. Micromeres were cultured in seawater alone (SW),
m and 10 AM UO126 (HS + UO126). QPCR data were normalized versus
) for each gene as described in Materials and methods.
Fig. 7. Inhibition of ERK activation blocks esophageal muscle formation
and reduces muscle-specific gene expression. (A) A control larva viewed
along the anal/oral surface and stained with FITC-labeled phalloidin, which
reveals filamentous actin, to show esophageal muscles (arrows). (B) A larva
in which ERK activity has been reduced from 9 h by adding 5 AM UO126,
viewed in the same orientation as in (A) to show the absence of muscle
fibers and coelomic pouches (cp) visible in the control. (A) and (B) are two-
dimensional projections of confocal images; fg, foregut; mg, midgut. (C)
Effect of reduction of ERK activity on the expression levels of muscle
(sum-1, actM), skeletogenic (sm50) and endodermal (endo16) genes
measured by QPCR as described in Fig. 6. Template cDNAs were prepared
from control (black bars) and UO126-treated embryos (pattern bars) at the
indicated developmental times.
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isolated. No detectable amounts of the other three genes
were found at the same stage. By 30 h, that is, by the time
when in whole embryos PMCs started to form a syncitium
and serum was added to cultured micromeres, all six genes
tested were showing considerable to high levels of expres-
sion relative to their maximum. At 72 h of development,
when the process of spicule formation was almost com-
plete in control embryos, expression of skeletogenic genes
was significantly diminished in whole embryos, while still
high in seawater cultured micromeres. This result, which is
a consequence of the enrichment of skeletogenic-specific
genes in isolated micromeres compared to the whole
embryo, confirms the finding of other work that shows
skeletogenic-specific genes expressed at significant levels
in isolated micromeres even in the absence of serum (Page
and Benson, 1992). All six genes reached their maximal
level of expression at 72 h in the sample cultured in the
presence of serum. The augmentation of levels of expres-
sion of these genes obtained in the presence of serum as
compared to seawater was partially or completely lost in
the sample cultured in the presence of UO126 (compare
bars in Fig. 6D). In a similar pattern to that observed in the
whole embryo (Table 3), the decrease in the level of
expression following reduction of ERK activity in serum
cultured micromeres was far more evident for the terminal
differentiation genes msp130, sm50 and sm30 (average
80% decrease in mRNA levels), than for the transcriptional
regulators ets1, tbr and erg (maximum 30% decrease in
mRNA levels).
ERK activation is required for muscle formation
Circumesophageal muscles in the sea urchin embryo
are derivative of a specific population of SMCs (Etten-
sohn, 1992). To determine if this SMC-derived cell type is
affected by inhibition of ERK activation, the appearance
of muscle fibers was quantified in control and UO126-
treated late stage pluteus larvae (96 h of development).
For this experiment, we used the drug at a concentration
(5 AM) that is less efficient at blocking formation of all
SMCs, but avoids exogastrulation. Even at low doses, the
drug inhibited the formation of muscle fibers as assessed
by actin staining using labeled phalloidin (Figs. 7A, B).
We analyzed under fluorescent confocal microscopy more
than 50 plutei stained with fluorescent phalloidin and
neither found traces of muscle fibers nor coelomic pouch
formation, even up to 5 days of development (not shown).
We used two markers for muscle cells, actin M (Cox et
al., 1986) and sum-1 (Beach et al., 1999), to measure the
effect of inhibition of ERK activation on muscle-specific
gene expression. Both mRNAs were down-regulated in
treated larvae, when assessed either at 50 or 70 h of
development (Fig. 7C). As expected and as control for
this experiment, the levels of expression of the endoderm-
specific gene endo16 were found only slightly affected,while sm50 mRNA was strongly down-regulated in larvae
with reduced ERK activity.Discussion
The spatio-temporal pattern of ERK activation visualized
in situ during sea urchin embryonic development (Figs. 1
and 2) is consistent with a general role of the MAP kinase-
mediated signaling pathway in the process of epithelial–
mesenchyme transition. The double phosphorylated/activat-
ed form of ERK is in fact localized in prospective primary
and secondary mesenchyme cells precisely when they are in
the process of undergoing EMT and it is down-regulated
immediately after their transition.
The phenotypes of the embryos in which the ERK-
mediated signaling has been either overactivated (by injec-
tion of Mekact) or inhibited (by treatment with the drug
M. Fernandez-Serra et al. / Developmental Biology 268 (2004) 384–402 397UO126 or by injection of Mekneg) suggest that this pathway
has a role in mesenchyme formation in the sea urchin. The
role of ERK signaling in primary and secondary mesen-
chyme formation is discussed below.
The function of ERK-mediated signaling in PMC and
spicule formation
The normal timing of ERK activation in the PMC
lineage, and the embryonic phenotypes obtained by prevent-
ing ERK activation for different time intervals, indicate that
this signaling pathway is required during the various steps in
the process of skeletogenesis. ERK is strongly activated in
the prospective PMCs at the early blastula stage (13–15 h)
and this active state is retained until first ingression occurs,
at least 6 h later (Fig. 2). Prevention of ERK activation in
the time interval just preceding the first event of activation
(9–12 h) fully blocks PMC ingression (Table 2). The
efficiency of this inhibition at stages as late as 12 h suggests
that the event of ERK activation in this lineage occurs
between 12 and 15 h. This temporal window rules out the
possibility of a role of the ERK signaling in the process of
initial specification of primary mesenchyme cells. On the
other hand, failure in blocking PMC ingression at times later
then 15 h suggests that the process of ingression mediated
by ERK signaling requires a more complex setup than just
an on/off switch. In support of this view, we measured
before and during ingression (15–24 h) a significant effect
of ERK on the transcriptional levels of some of the genes
that control the PMC regulatory network. We found that
ERK signaling positively regulates two genes required for
both primary ingression and skeletogenesis, alx1 (Ettensohn
et al., 2003) and ets1 (Kurokawa et al., 1999), and two more
genes specifically involved in skeletogenesis, dri (Amore et
al., 2003) and tbr (Croce et al., 2001; Fuchikami et al.,
2002). The relationships that link these genes in the PMC
regulatory network indicate that Ets1 and Alx1 control the
transcription of tbr and dri, respectively, which suggests that
tbr and dri might be secondary targets of ERK signaling. In
S. purpuratus, both alx1 (Ettensohn et al., 2003) and ets1
(Fernandez-Serra and Arnone, unpublished) transcripts are
present and confined to the micromere lineage before the
first event of ERK activation in these cells. Although not a
prerequisite for the onset of zygotic transcription of these
two genes, ERK signaling is nonetheless required for
maintenance of their transcriptional levels during develop-
ment. Our time course RNA measurements indicate that the
transcriptional control mediated by ERK signaling on alx1
precedes that on ets1 (Table 3). On the other hand, Ets1 is
the best candidate as a direct nuclear target of ERK
signaling in the PMC lineage. The sea urchin ets1 gene
contains a highly conserved domain, the POINTED (PNT)
domain, which includes the consensus site for MAP kinase
in its amino-terminal region (Graves and Petersen, 1998).
Recently, an ERK docking site has been identified on the
surface of the mammalian Ets-1 PNT domain, and thissequence is conserved in the Drosophila ets member point-
ed but not in the PNT domain of other ets proteins (Seidel
and Graves, 2002). This site is also conserved in S.
purpuratus ets1 (Fernandez-Serra and Arnone, unpub-
lished). Although we do not have evidence that Ets1 is a
direct target of ERK in sea urchin embryos, it is likely that
Ets1 mediates most of the observed effects of ERK signal-
ing on PMC specification and ingression. The observation
that Ets1-morpholino-injected embryos present significant
perturbations of most of the genes participating to this
network (P. Oliveri, personal communication) is in support
of a central role of Ets1 in the PMC regulatory network.
ERK signaling is required for at least two other morpho-
genetic processes in the PMC lineage: (1) the spatial
organization of PMCs and (2) skeletogenesis. After ingres-
sion into the blastocoel, PMCs migrate on the inner surface
of the gastrula wall by means of numerous filopodia, where
they eventually arrange in a ring. During migration, filopo-
dia fuse to form a syncitial network of connecting cables
within which spicule formation is initiated. Several lines of
evidence suggest that PMCs require interaction with the
ectodermal wall for proper spatial arrangement and spiculo-
genesis (Malinda and Ettensohn, 1994; Peterson and
McClay, 2003; Zito et al., 1998). Our results of inhibition
of ERK activation after ingression of PMCs (Tables 1 and 2)
suggest that ERK signaling is involved in the control of both
PMC cluster formation and subsequent processes of skeleto-
genesis. Both ets and erg transcripts are present in PMCs
during gastrulation (Fernandez-Serra and Arnone, unpub-
lished) and could be responsible for these late effects as
direct targets of ERK. However, due to the presence of
slight activity of ERK in the oral ectoderm at gastrula stages
(not shown), we cannot rule out the possibility that these
late effects on spiculogenesis are indeed a result of interfer-
ence with the PMC–ectoderm interaction. Consistent with
the hypothesis of a role of ERK activity in the ectodermal
domain, we observed in UO126-treated embryos a reduction
at 32–48 h of development on the level of expression of two
genes, elk and eve, which at gastrula stage are expressed in
the oral ectoderm (Table 3).
The large micromere lineage is autonomously pro-
grammed to give rise to skeletogenic cells. A classic exper-
iment that demonstrates the potential of these cells is the in
vitro production of spicules from isolated micromeres cul-
tured in the presence of horse serum (Okazaki, 1975). Our
experiments of inhibition of ERK activation in cultured
micromeres demonstrate that ERK-mediated signaling is
required for in vitro spicule formation in the presence of
serum. The study of skeletogenic-specific gene expression in
presence of active ERK or reduced ERK also suggests that the
signaling cascade downstream of ERK operates in the isolat-
ed micromeres in a similar fashion compared to the whole
embryo (Table 3 and Fig. 6). These results strengthen the
hypothesis that an additional signal is required to execute the
entire skeletogenic program of these cells. Although, as
displayed by their name, these kinases are known to be
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could also be activated by intracellular cues (Lewis et al.,
1998). The observation that, in isolated micromeres, the
effects of serum on skeletogenic-specific gene expression
are quantitatively abolished by inhibition of ERK activation,
suggest that ERK activation in the micromere lineage is
indeed triggered by extracellular signals. While the nature
of this intra- or extracellular, autocrine or exocrine signal
remains still unknown, it is likely that ERK is downstream of
the early gene network that directs micromere specification
(Ettensohn et al., 2003; Oliveri et al., 2002).
The function of ERK-mediated signaling in SMC formation
and differentiation
In this study, we have examined the effect of ERK
inactivation in secondary mesenchyme cell (SMC) deriv-
atives and observed loss of all of these differentiated cell
types: pigment cells, circumesophageal muscles, coelomic
pouches and blastocoelar cells (Tables 1 and 2; Fig. 3).
Here, we studied in detail the role of ERK signaling in
the process of pigment and muscle cell formation.
SMCs are induced through a Delta!Notch signaling
pathway in the sea urchin embryo. Several studies demon-
strated that the Delta signal, which emanates from the
descendants of the large micromeres to activate the Notch
protein in the neighboring veg2-derivatives cells, occurs
around the 8th to 10th cleavage stage (10–12 h in S.
purpuratus) (Sherwood and McClay, 1999; Sweet et al.,
1999, 2002). The timing of the ERK activation under
normal conditions in the prospective SMC domain (15–
19 h), and the effect of perturbation of this activation at
different developmental times observed in this study, sug-
gest that ERK signaling occurs downstream of the early
Delta!Notch induction. Interestingly, high doses of
Mekact injection produce embryos (Fig. 5) that closely
phenocopy the Notchact overexpression in the extra pro-
duction and extrusion of pigment cells (Sherwood and
McClay, 1999). Moreover, we both temporally and quan-
titatively assessed the role of ERK in pigment cell forma-
tion by measuring the effect on the transcription of two
terminal differentiation genes of these cell types, pks
(Calestani et al., 2003) and dpt (Rast et al., 2002). We
demonstrated that, while these two genes are strongly
down-regulated following reduction of ERK activation,
the gene gcm, which is an SMC-specific transcriptional
regulator restricted to the pigment cell lineage during
gastrulation (Ransick et al., 2002), is only moderately
affected at later stages (Table 3). It has been recently
demonstrated that gcm acts in the SMC lineage as one of
the first responses of the Delta!Notch signaling that
controls the transcription of both pks and dpt (A. Ransick
and E.H. Davidson, personal communication). Our obser-
vations show that, although the onset of transcriptional
activation of gcm is independent of ERK-mediated signal-
ing, maintenance of gcm expression requires ERK activa-tion. In addition, we found that ERK is indispensable for
the transcription of pigment cell terminal differentiation
genes. The most likely direct target of ERK activation in
this cell lineage is the protein Erg. This is a good candidate
because SpErg contains the ERK docking site recently
found in the PNT domain of some ets proteins (Seidel
and Graves, 2002) and it is present in the SMC lineage at
the time of ERK activation (Fernandez-Serra and Arnone,
unpublished observations). At later stages, another direct
target of ERK signaling in this lineage could be Ets1, as
ets1 transcripts accumulate during gastrulation also in
SMCs (Fernandez-Serra and Arnone, unpublished results).
Whereas pigment cells are specified before and differen-
tiate during gastrulation, other SMCs derivatives, such as
muscle cells, complete their developmental program during
later stages. We demonstrated that ERK activation is also
required for the formation of muscle fibers by transcription-
al control of two muscle-specific genes, actin M (Cox et al.,
1986) and the myo-D homologue sum-1 (Beach et al., 1999)
(Fig. 7). A similar effect, as that observed after inhibition of
ERK activation, was obtained using inhibitors of the fibro-
blast growth factor (FGF) receptor (Fernandez-Serra and
Arnone, unpublished). Interestingly, a FGF receptor protein
has been found which is specifically localized in prospective
muscle cells at late gastrula and in muscle fibers at pluteus
stage in S. purpuratus (McCoon et al., 1998). Taken
together, these observations strongly suggest that FGF
signaling, mediated by ERK activation cascade, induces
muscle formation in the sea urchin embryo.
Pan-mesodermal role of ERK-signaling in EMT
In both primary and secondary mesenchyme cells, ERK
signaling appears to have a double role: control of morpho-
genetic changes and tuning of gene expression specific to
these cell types. The timing and the extent of the control over
gene expression by these genes suggest a possible common
mechanism of action (Fig. 8). As discussed in detail in the
two previous sections, ERK signaling is not required for the
early specification of either PMCs or SMCs, although it
controls the maintenance and/or enhancement of expression
of regulatory genes which participate to the process of
specification of both these cell types, before they undergo
epithelial-mesenchyme transition (EMT). In contrast to early
specification events, ERK signaling is strongly required for
transcription of mesenchymal terminal differentiation genes,
which are significantly transcribed only after EMT. In
addition, the phenotype of ERK inhibited embryos evidently
shows that ERK signaling is required for EMT in both PMCs
and SMCs. In previous studies, we identified a cis-regulatory
device capable of specifically driving expression in both
PMCs and SMCs, thus supporting the existence of a pan-
mesodermal regulatory program in the sea urchin embryo
(Consales and Arnone, 2002; Martin et al., 2001). Interest-
ingly, this cis-regulatory element contains an essential con-
sensus sequence for the ets family of transcription factors.
Fig. 8. Role of the ERK signaling pathway in the PMC and SMC lineages. The regulatory cascade for both lineages are represented in two parallel diagrams,
from early specification (top) to terminal differentiation (bottom), not considering their respective time of occurrence during embryo development. Continuous
arrows indicate events of transcriptional activation. Dotted arrows indicate transduction of signaling pathways. The asterisk on ERK, Ets and Erg indicates that
these proteins are phosphorylated as a consequence of the signaling cascade. The asterisk on the arrows emanating from ERK indicates that the transcriptional
activation downstream of ERK is mediated by transcription factor(s) phosphorylated by this kinase. The time of first activation of ERK in both lineages is
indicated in parenthesis. The two diagrams are connected by the Delta!Notch signaling pathway, which triggers early specification in the SMC lineage
(Sherwood and McClay, 1999; Sweet et al., 2002). Receptor tyrosine kinases (RTK) are included in the diagram. While there is evidence for the involvement of
FGF/FGFR signaling in muscle formation (this study; McCoon et al., 1998), the other inductions are not known (question marks) and could be mediated by
different receptors (x, y, z). The arrow emanating from the box of PMC or SMC regulatory genes to the box of epithelial–mesenchyme transition (EMT) genes
implies that some of the former could indeed regulate the latter. There is evidence for such a case for Ets1 (Kurokawa et al., 1999) and Alx1 (Ettensohn et al.,
2003) in the PMC lineage, while no such gene has so far been found in the SMC lineage (question mark).
M. Fernandez-Serra et al. / Developmental Biology 268 (2004) 384–402 399The present study shows that in both PMCs and SMCs at
least one member of this family could be a direct target of
ERK kinase and therefore mediate the control that ERK
signaling has on both EMT and terminal differentiation. In
conclusion, our prediction is that ERK signaling, probably
mediated by members of the ets family of transcription
factors, must control the transcription of still unknown genes
(squared boxes in Fig. 8), which are required for EMT in all
mesenchymal cell types of the sea urchin embryo. In
addition, we suggest that ERK signaling has an important
pan-mesodermal role in coupling the EMT and terminal
differentiation of these mesenchymal cell types.
The function of ERK-mediated signaling in endoderm
formation
Our experiments of perturbation of the ERK-mediated
signaling demonstrate minor effects on sea urchin endoderm
formation. Among the eight genes analyzed that participate
to the endoderm network of specification, that is, bra, elk,
endo1, endo16, eve, foxA, lim and gataE, only eve and elk
exhibited significant alterations of their expression follow-
ing inhibition of ERK signaling. Moreover, this alteration
occurred only late in gastrulation and could therefore be dueto secondary effects. The most significant consequence of
perturbation of ERK signaling pathway on gut formation
was the high occurrence of exogastrulation observed in
embryos treated with high doses of the drug UO126.
However, the displacement of the gut in these embryos
did not interfere with gut differentiation in the final larvae.
Although this work did not further address this point, it
could be inferred that the morphogenetic changes observed
were due to mechanical effects, such as interference of the
ERK-mediated signaling with the formation of bottle cells
(Burke et al., 1991).
Conservation of ERK-mediated signaling in development
Although the MAP kinase activation cascade is not the
only signaling pathway downstream of receptor tyrosine
kinases (RTK), ERK proteins can be viewed as a common
universal denominator of different RTK-mediated cell fate
decisions. The nodal point they represent is exemplified by
the fact that mutations in ERK genes phenocopy the loss of
the RTKs that activate them. This aspect is well illustrated
by the cases of the eye development in Drosophila (Wassar-
man et al., 1995) and vulva induction in Caenorhabditis
elegans (Sundaram and Han, 1996).
M. Fernandez-Serra et al. / Developmental Biology 268 (2004) 384–402400In contrast to this unidirectional transduction of RTKs-
mediated signaling to ERK activation, there is a multitude of
signaling pathways upstream and diverse developmental
outcomes downstream in different species and cells. The
FGF signaling pathway appears to play a central role in both
vertebrates and ascidians: the atlas of ERK activation in the
mouse embryo almost completely overlaps with the regions
of FGF signaling (Corson et al., 2003); a FGF/Ras/MEK/
ERK signaling cascade is involved in induction of noto-
chord, mesenchyme and brain in the ascidian embryo
(Hudson et al., 2003; Minokawa et al., 2001; Miya and
Nishida, 2003; Shimauchi et al., 2001). In contrast to that, in
the Drosophila embryo, the dynamic atlas of activated ERK
during development can be attributed to at least four
different RTKs: torso, the epidermal growth factor receptor
DER and two FGF receptors, Heartless and Breathless
(Gabay et al., 1997). Our findings indicate that in the sea
urchin, an FGF/ERK-mediated signaling is only required for
muscle formation during embryonic development. There are
several lines of evidences which explain the involvement of
other RTKs in spiculogenesis and gastrulation in the sea
urchin embryo (Govindarajan et al., 1995; Ramachandran et
al., 1995, 1997), but there are no descriptions of RTK
patterns of expression with the sole exception of the FGF
receptor in muscle cells (McCoon et al., 1998). These
observations suggest that in the sea urchin, as in the case
of Drosophila, different RTKs would be responsible for
ERK activation and subsequent outcomes in different cells
(see the scheme in Fig. 8).
In all these cases, the interesting open question remains
as to how embryonic cells can act differently in response to
the same signal (activation of ERK). Recently, a model has
been proposed which postulates that RTKs generally act via
the same signaling cassette, producing a ‘generic’ signal, but
cells interpret these signals according to their distinct
developmental history (Dossenbach et al., 2001; Simon,
2000). The role played by the ERK signaling pathway in
the PMC and SMC lineages as proposed in Fig. 8 is in line
with this model. Further studies on different members of the
ets family of transcription factors and other possible ERK
targets in the mesenchyme cells of the sea urchin embryo
will provide a good system to elucidate how cells can
respond in different ways to the same signaling cassette.Acknowledgments
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